We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

214 hedge funds and large institutions have $1.82B invested in Beam Therapeutics in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 73 increasing their positions, 62 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $16.6M | Put options by funds: $7.11M

18% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 62

8.14% more ownership

Funds ownership: 86.14% → 94.28% (+8.1%)

3% less funds holding

Funds holding: 221 → 214 (-7)

12% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 41

22% less capital invested

Capital invested by funds: $2.32B → $1.82B (-$504M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
214
Holders Change
-7
Holders Change %
-3.17%
% of All Funds
3.09%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
36
Increased
73
Reduced
62
Closed
41
Calls
$16.6M
Puts
$7.11M
Net Calls
+$9.45M
Net Calls Change
+$24.8M

Top Buyers

1
AVM
Arch Venture Management
Illinois
+$134M
2
FCM
Farallon Capital Management
California
+$83.5M
3
First Trust Advisors
First Trust Advisors
Illinois
+$36.4M
4
BlackRock
BlackRock
New York
+$22.8M
5
Deutsche Bank
Deutsche Bank
Germany
+$19.7M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$81.5M
2
DGM
Darwin Global Management
Jersey
-$70M
3
AIM
ARK Investment Management
Florida
-$13.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$12M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$7.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
101
Federated Hermes
Pennsylvania
$488K +$512K +20,839 New
Envestnet Asset Management
102
Envestnet Asset Management
Illinois
$481K -$39.3K -1,602 -7%
ASRS
103
Arizona State Retirement System
Arizona
$455K +$9.63K +392 +2%
SG Americas Securities
104
SG Americas Securities
New York
$448K +$320K +13,018 +213%
BFEC
105
Benjamin F. Edwards & Company
Missouri
$445K +$457K +18,598 +4,843%
VA
106
Vident Advisory
Georgia
$432K -$23.3K -947 -5%
SW
107
SteelPeak Wealth
California
$417K +$253K +10,290 +137%
Handelsbanken Fonder
108
Handelsbanken Fonder
Sweden
$412K +$17.2K +700 +4%
Los Angeles Capital Management
109
Los Angeles Capital Management
California
$393K -$27.1K -1,105 -6%
Mercer Global Advisors
110
Mercer Global Advisors
Colorado
$375K -$31K -1,264 -7%
Teacher Retirement System of Texas
111
Teacher Retirement System of Texas
Texas
$357K -$4.32K -176 -1%
ProShare Advisors
112
ProShare Advisors
Maryland
$353K -$109K -4,439 -23%
HSBC Holdings
113
HSBC Holdings
United Kingdom
$332K +$352K +14,341 New
BC
114
Bridgefront Capital
Texas
$322K +$338K +13,755 New
TCM
115
Teza Capital Management
Illinois
$320K -$59.7K -2,429 -15%
Osaic Holdings
116
Osaic Holdings
Arizona
$303K -$25.7K -1,048 -8%
CAM
117
ClariVest Asset Management
California
$300K -$688 -28 -0.2%
Simplex Trading
118
Simplex Trading
Illinois
$290K +$305K +12,417 New
GAA
119
Green Alpha Advisors
Colorado
$276K -$45.7K -1,859 -14%
Mitsubishi UFJ Asset Management
120
Mitsubishi UFJ Asset Management
Japan
$272K +$97.5K +3,970 +52%
AG
121
Algert Global
California
$267K +$280K +11,393 New
HTHT
122
Hemenway Trust Hemenway Trust
New Hampshire
$252K – – –
Principal Financial Group
123
Principal Financial Group
Iowa
$244K -$197K -8,018 -44%
EFM
124
E Fund Management
China
$235K -$37.1K -1,510 -13%
JAFL
125
Jay A. Fishman Ltd
Michigan
$234K – – –
3 4
5
6 7

BEAM Hedge Fund Activity: Q2 2024 in Review

214 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q2 2024, worth a combined $1.82B — down 22% from $2.32B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of BEAM and 36 opened new positions — a net loss of 5 holders — while 62 trimmed existing stakes and 73 added.

The largest buyer was Arch Venture Management, opening a new position worth an estimated $134M. The largest seller was Morgan Stanley, cutting an estimated $81.5M.

  • 214 institutional investors held Beam Therapeutics (BEAM) as of Q2 2024, down from 221 in Q1 2024.
  • Funds reported $1.82B of Beam Therapeutics stock for Q2 2024, down 22% quarter-over-quarter.
  • 36 funds opened new Beam Therapeutics positions in Q2 2024 and 41 closed out, a net change of -5 holders.
  • The largest Beam Therapeutics buyer in Q2 2024 was Arch Venture Management, an estimated $134M added.
  • The largest Beam Therapeutics seller in Q2 2024 was Morgan Stanley, an estimated $81.5M sold.

Based on aggregated 13F filings for Q2 2024.